In contrast, SNX3 and LGALS2 are antitumor factors that inhibit tumor cell growth and metastasis (Li et al., 2021b; Yu et al., 2022), which is consistent with the phenotype of type I conventional DCs. The gene discussed is LGALS2; the disease is neoplasm.